Internal Medicine, Hematology & Oncology · Fort Smith, AR
NPI
1790904027
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
6801 Rogers Ave Ste 200
Fort Smith, AR, 72903
Phone (479) 274-5260
Groups this clinician bills Medicare through
Medicare paid, 2024
$241K
3,811 services
Medicare patients, 2024
857
Average age 74
Drug cost, 2024
$10.3M
6,917 prescriptions
Company payments, 2025
$1,364
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Varant B Arzoumanian was code 99214 (office e&m - established), 1,451 times for 300 patients. In total Varant B Arzoumanian billed 3,811 services in 16 codes, and Medicare paid $241K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 1,451 | 300 | $65.82 | $96K |
| 99213 Office E&M - Established | Facility | 795 | 470 | $41.32 | $33K |
| 99232 Hospital E&M - Subsequent | Facility | 746 | 207 | $56.01 | $42K |
| 99223 Hospital E&M - Initial | Facility | 195 | 164 | $117.14 | $23K |
| 99215 Office E&M - Established | Facility | 195 | 111 | $98.67 | $19K |
| 99203 Office E&M - New | Facility | 86 | 86 | $45.54 | $3,917 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 75 | 71 | $12.02 | $902 |
| 99205 Office E&M - New | Facility | 72 | 72 | $117.92 | $8,490 |
| 99222 Hospital E&M - Initial | Facility | 60 | 58 | $91.30 | $5,478 |
| 99204 Office E&M - New | Facility | 55 | 55 | $83.64 | $4,600 |
| 99233 Hospital E&M - Subsequent | Facility | 54 | 34 | $83.22 | $4,494 |
| 99212 Office E&M - Established | Facility | 17 | 16 | $17.64 | $300 |
By year: 2022 $421K for 7,450 services; 2023 $325K for 4,744 services; 2024 $241K for 3,811 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,322 | 743 | $2.97 | $6,889 |
Medicare prescription drug claims, 2024
In 2024, the drug Varant B Arzoumanian prescribed most often to Medicare patients was Letrozole, with 505 prescriptions and refills. In total Varant B Arzoumanian wrote 6,917 Medicare prescriptions that cost $10.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 505 | 945 | 118 | $7,688 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 362 | 362 | 89 | $9,751 |
| Ondansetron Hcl Generic | 310 | 311 | 91 | $2,175 |
| Potassium Chloride Generic | 261 | 366 | 81 | $2,972 |
| Prochlorperazine Maleate Generic | 258 | 258 | 124 | $3,384 |
| Ondansetron Odt Ondansetron | 217 | 217 | 96 | $2,185 |
| Hydroxyurea Generic | 202 | 316 | 40 | $4,134 |
| Gabapentin Generic | 195 | 209 | 52 | $1,549 |
| Eliquis Apixaban | 180 | 211 | 38 | $119K |
| Prednisone Generic | 178 | 208 | 76 | $806 |
| Tamoxifen Citrate Generic | 173 | 273 | 28 | $3,228 |
| Oxycodone Hcl Generic | 169 | 170 | 37 | $4,235 |
| Alendronate Sodium Generic | 155 | 277 | 40 | $988 |
| Dexamethasone Generic | 154 | 174 | 62 | $2,304 |
| Levothyroxine Sodium Generic | 153 | 193 | 30 | $567 |
Brand drugs: 1,139 claims; generic drugs: 5,778 claims; opioid claims: 713.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Varant B Arzoumanian $1,364 ($1,364 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $181.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 7 | $181 |
| Merck Sharp & Dohme LLC MRK | 8 | $146 |
| Daiichi Sankyo Inc. 4568.T | 7 | $139 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $136 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $135 |
| Gilead Sciences, Inc. GILD | 6 | $115 |
| Pfizer Inc. PFE | 9 | $112 |
| Celgene Corporation BMY | 3 | $67.14 |
| Astellas Pharma US Inc 4503.T | 3 | $53.33 |
| GlaxoSmithKline, LLC. GSK | 3 | $51.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.